Proxim Diagnostics

Proxim Diagnostics is a medical device company based in Santa Clara, California. The company specializes in developing handheld immunodiagnostic devices that enable highly sensitive testing at the point of care using whole blood samples. Their technology aims to bring critical laboratory tests closer to patients, facilitating faster and more accessible diagnostics. The company focuses on infectious and cardiovascular diseases, with a pipeline of approximately nine in vitro diagnostic products currently in early development stages. Proxim Diagnostics' flagship offering is a handheld platform that utilizes proprietary biosensor and cartridge technologies to deliver high sensitivity immunoassays in a compact, user-friendly device. This technology enhances clinical decision-making by providing timely and accurate test results outside traditional laboratory settings. Proxim Diagnostics serves healthcare providers, clinics, and hospitals that require rapid diagnostic testing. The company has raised around $22.9 million in funding and has an estimated enterprise valuation between $72 million and $108 million as of late 2022. Their team consists of experts in biosensor design and medical devices, highlighting their commitment to innovation in diagnostic testing.

• Employees 12
• Founded 2009
• Annual Revenue $2500000
• Total Funding $4904355